UltimateDX uses detailed molecular testing to identify respiratory tract infections. We are able to identify slow growing cultures of various pathogens that can cause issues in the respiratory system.
Respiratory Tract Infections are diseases that are caused by infections in the upper or lower respiratory tract. The upper respiratory tract includes areas such as the nose, sinuses, pharynx, and larynx. While infections can take on many different forms, upper respiratory tract infections typically include symptoms of coughing, sneezing, nasal discharge, runny nose, fever, sore throat, and nasal breathing. Upper respiratory tract infections can be any infection in the upper tract and may be diagnosed as varying conditions. Some conditions that are considered upper respiratory tract infections are tonsillitis, laryngitis, pharyngitis, sinusitis, or the common cold. Lower respiratory tract infections differ from upper respiratory tract conditions due to the location of the infection, typically located in the trachea, bronchial tubes, or lungs. They usually result in conditions such as bronchitis or pneumonia.
Our capabilities to test for respiratory infections include bacterial, viral, and fungal pathogen detection. Typically, identifying respiratory tract infections have been difficult due to the methods previously used to culture identifying pathogens. UltimateDX uses molecular diagnostic technology that allows us to bypass the standard methods of pathogen culturing to obtain accurate and timely results.
UltimateDX is a CLIA certified high complexity lab with expertise in research and development of many laboratory developed tests (LDTs).
UltimateDX Laboratories, the world leader in providing PCR and Next Generation DNA Sequencing in microbial identification, has validated a real-time Reverse Transcriptase PCR (rRT-PCR) assay for the specific detection of the SARS-CoV-2 virus. UltimateDX has been validated for nasal swabs, sputum, and saliva samples for COVID-19 testing.
UltimateDX Laboratory COVID-19 Testing Status and Approval for Diagnostic Testing for SARS-CoV-2 using Nasal Swabs, Sputum and Saliva Samples.
Detection of the SARS-CoV-2 virus. The assay validation exceeds the minimum recommendations put forth by the FDA guidance policies and has been determined to be 100% specific and sensitive in vitro. CLICK HERE to review the UDX SARS-CoV-2 Molecular Diagnostic Validation Summary
We have been validated and added to the FDA Website as a resource laboratory for COVID-19 Testing.
UltimateDX’s COVID-19 Rapid PCR Test has a 24-hour turn around time from time of receipt.
UltimateDX laboratory has been validated to offer the COVID-19 TEST utilizing nasal swabs, sputum and saliva samples.
UltimateDX will have the capacity to process 10,000 samples per day.